Mass High Tech
NOBLEGEN BIOSCIENCES INC
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
About:
NobleGen Biosciences is building a novel DNA sequencing instrument to enable cost effective personalized medicine, based on highly differentiated IP exclusively licensed from Harvard University and Boston University.
Headlines from Mass High Tech about NOBLEGEN BIOSCIENCES INC
Print this Listing
Product Information
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
Details
| Year Established | 2010 |
| Ownership Type | Private |
| Total Number Employees | Subscriber access only |
Contacts
| Frank Feist | CEO | email available to subscribers | ||
| Amit Meller | Acting CTO | |||
| Philip Buzby | VP Biochemistry | |||
| Wolfgang Oster | Chairman | |||
| Gavriel Meron | Director |
* Downloads will not contain Personnel E-mail addresses
Search the Directory
Company Overview
| Focus | Biotechnology - Pharmaceutical |
| Location | Concord, MA |
| Website | http://www.noblegenbio.com |
| Revenue | Subscriber access only |
Contact Information
| Address |
58 Elsinore St Concord, MA, 01742 |
| Phone | 978-405-2533 |
| Website | www.noblegenbio.com |
New England Tech Directory
| Browse
| Subscribe
| Advertise
| Networking
| About Us
| Search
| 
RSS Feeds
| 
| Directory License
| Update User Info
| Directory Privacy Policy
| Logout
© 2012 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.
Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com
Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.